van Dongen Ivo M, Winter Jobst, Aben Bart, Wijntjens Gilbert W M, Delewi Ronak, Siebers Jan, Kok Robin N, Schaafsma Frederieke G
De Nieuwe Arts, Occupational Health Service, Amsterdam, The Netherlands.
Department of Public and Occupational Health, Amsterdam UMC, Outpatient Clinic for Occupational Health Medicine, Amsterdam, The Netherlands.
Neth Heart J. 2025 Sep 15. doi: 10.1007/s12471-025-01989-6.
There is very limited data available on the impact of cardiovascular disease (CVD) on absenteeism occurrence, absenteeism duration, and the associated rough cost-estimate for employers.
We extracted routinely collected absenteeism data for the years 2019-2022 from a database maintained by two large, nationally operating occupational health services (n = 443,740). All diagnoses and included sickness cases were recorded > 6 weeks of absenteeism. Descriptive statistics, including median values (IQR) and percentages, were calculated and compared using the Mann-Whitney U test and Pearson chi-square test. Subgroup comparisons were performed using the Kruskal-Wallis test. To analyse return-to-work over time, a Kaplan-Meier curve was constructed, and differences in return-to-work were assessed using the Log Rank (Mantel-Cox) test.
CVD is the primary cause of absenteeism in 3.2% of all absenteeism cases. The median duration of absenteeism following CVD was 119 working days (IQR 156; Q1-Q3 62.9-218.6) with a minimum rough cost-estimate to employers of € 37,000 per employee. The most frequently occurring CVD diagnoses were: acute myocardial infarction, cerebrovascular disease, cardiac arrhythmia, unspecified cardiovascular complaints and angina.
CVD occurs frequently, results in prolonged absenteeism, and incurs high costs for employers. We strongly believe that CVD-related absenteeism should receive greater attention. Specifically, both in-hospital and outpatient treatments should place a stronger emphasis on work-related issues, including strategies for returning to work with or without tailored assignments in the workplace. This focus will help ensure that employees can sustainably return to work and continue to contribute to society.
关于心血管疾病(CVD)对旷工发生率、旷工持续时间以及雇主相关粗略成本估计的影响,现有数据非常有限。
我们从两个全国性运营的大型职业健康服务机构维护的数据库中提取了2019 - 2022年定期收集的旷工数据(n = 443,740)。所有诊断和纳入的病假案例记录的旷工时间均超过6周。计算描述性统计数据,包括中位数(四分位间距)和百分比,并使用曼 - 惠特尼U检验和皮尔逊卡方检验进行比较。亚组比较采用克鲁斯卡尔 - 沃利斯检验。为了分析随时间的复工情况,构建了 Kaplan - Meier 曲线,并使用对数秩(曼特尔 - 考克斯)检验评估复工差异。
在所有旷工案例中,3.2%的案例主要病因是心血管疾病。心血管疾病后的旷工中位数持续时间为119个工作日(四分位间距156;第一四分位数 - 第三四分位数62.9 - 218.6),每位员工给雇主带来的最低粗略成本估计为37,000欧元。最常出现的心血管疾病诊断为:急性心肌梗死、脑血管疾病、心律失常、未明确的心血管疾病主诉和心绞痛。
心血管疾病频繁发生,导致旷工时间延长,并给雇主带来高昂成本。我们坚信与心血管疾病相关的旷工问题应得到更多关注。具体而言,住院和门诊治疗都应更加强调与工作相关的问题,包括有无在工作场所进行量身定制任务情况下的复工策略。这种关注将有助于确保员工能够可持续地重返工作岗位并继续为社会做出贡献。